Gene signature may give an upper hand in metastatic breast cancer
A new strategy to refine breast cancer diagnosis could help guide a more precise selection of tumor-specific treatments.
Read more
Metastatic breast cancer
Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy
Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.
Read more
Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer
About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen
Read more
Understanding the importance of metastatic breast cancer research
You’ve likely seen a lot of information about the importance of breast cancer screenings and prevention this month. However, until recently, little was known about
Read more
A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer
There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads
Read more